The largest database of trusted experimental protocols
Sourced in United States, France

C. albicans is a species of yeast that is commonly found in the human gut and on the skin. It is a widely studied model organism in microbiology and is often used in laboratory research.

Automatically generated - may contain errors

49 protocols using c albicans

1

Antimicrobial Activity of GA-AgNPs

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial activity of the GA-AgNPs against three bacterial strains: S. sanguinis (NCTC 7865), S. mutans (NCTC 10449), L. acidophilus (ATCC 314), and one fungal strain C. albicans (ATCC 10231) was determined using the agar disc diffusion and the microdilution assays. The S. sanguinis and S. mutans were purchased from Davies Diagnostics (Randburg, Johannesburg, South Africa); and L. acidophilus and C. albicans were purchased from the American Type Culture Collection (ATCC; Manassas, Virginia, USA).
All the microbes were cultured on Brain Heart Infusion (BHI) Broth (Sigma–Aldrich), and single colonies were subcultured in BHI agar (Sigma–Aldrich) for all the bacterial strains and Sabouraud dextrose agar for C. albicans at 37°C for 24 hours. Following the overnight incubation, the microbes were adjusted to the 0.5 McFarland standard (Mcf) using DensiCHEK Plus standards (BioMérieux, Inc., Durham, NC, USA).
+ Open protocol
+ Expand
2

Antimicrobial Efficacy of Hand Sanitizers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gram-positive and gram-negative bacteria, as well as an opportunistic pathogenic yeast (C. albicans), were obtained from the American Type Culture Collection (ATCC) as reference microbes to test the antimicrobial efficiency of prepared hand sanitizers. The bacterial isolates included: Acinetobacter baumannii (A. baumannii)—BAA 747, Escherichia coli (E. coli)—ATCC 25922, K. pneumoniae—BAA 1705, two strains of Pseudomonas aeruginosa (P. aeruginosa)—BAA 1744 and ATCC 27853, and S. aureus strains—ATCC 29,213 and BAA 977. Other bacterial strains were either isolated clinically or environmentally, which included: E. coli—isolates 1060, Staphylococcus epidermidis (S. epidermidis)—isolate 5029, Staphylococcus hominis (S. hominis)—isolate 5028, Staphylococcus haemolyticus (S. haemolyticus)—isolate 5034, and Micrococcus luteus (M. luteus)—isolate SB 115. The yeast C. albicans—ATCC 66,027 was obtained from ATCC. The bacterial and yeast suspensions, also known as inoculums, were all prepared in Mueller–Hinton broth by measuring 0.5 McFarland, according to [19 (link)]. All microorganisms were cultured on Mueller–Hinton agar medium and incubated at 37 °C overnight.
+ Open protocol
+ Expand
3

Characterizing Antifungal Susceptibility of Candida Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eighteen Candida strains (three strains of each of six species) were selected depending on their prevalence in medical pathologies. They were all fully characterized using MALDI-TOF MS (VITEK MS, bioMérieux, Marcy-l' Étoile, France) and their antifungal susceptibility tested (eTest R , bioMérieux) as recommended by the manufacturer, to verify expected results regarding azoles susceptibility. Four were American Type Culture Collection (ATCC, Manassas, VA, USA) strains: azole-susceptible C. albicans ATCC 90028, azolesusceptible C. albicans ATCC 10231, azole-susceptible C. glabrata ATCC MYA2950, and fluconazole-resistant C. krusei ATCC 6258). The 14 others were isolated from clinical samples: one azole susceptible C. albicans, two azole susceptible C. glabrata (fluconazole = 2 μg/ml, voriconazole = 0.023 μg/ml), three azole-resistant C. glabrata (fluconazole >256 μg/ml; voriconazole >32 μg/ml), two naturally resistant C. krusei and three of each naturally resistant C. lipolytica and C. inconspicua. 16 Before use, to work with strains in exponential growth phase, all were cultured for 24 hours on ChromID CAN2 (bioMérieux).
+ Open protocol
+ Expand
4

Antifungal Activity of Vitex agnus-castus

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eleven Candida strains were used to assess the antifungal activity of Vitex agnus-castus. The species were four strains purchased from (ATCC, Manassas, VA, United States) included C. albicans (ATCC® 60,193™), C. krusei (ATCC® 14,243™) (Ck1), C. parapsilosis (ATCC® 22,019™) (Cp1), C. tropicalis (ATCC® 66,029™). Other seven strains were obtained from either King Khalid University Hospital (KKUH), or King Abdullah International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia, and included C. parapsilosis (Cp2), Candida famata, C. rhodotorula, C. dublinesis, C. auris, C. krusei (Ck2), and C. krusei (Ck3). The fresh inoculum was prepared by subculturing the studied species onto a Sabouraud dextrose agar (SDA) medium at 28 °C for 48 h, as previously described [23 (link)]. The turbidity of growing Candida suspension was adjusted to match the turbidity standard of 0.5 McFarland units, by spectrophotometry tune of 0.1 OD and was read at 600 nm wavelength.
+ Open protocol
+ Expand
5

Antimicrobial Activity Assessment

Check if the same lab product or an alternative is used in the 5 most similar protocols
Fresh overnight cultures of various aerobically grown reference strains of bacteria and yeasts from the American Type Culture Collection (ATCC) were used in all experiments. The panel of the tested microorganisms included Gram-positive bacteria: Staphylococcus aureus ATCC 6538, Staphylococcus epidermidis ATCC 12228, Micrococcus luteus ATCC 10240, and Bacillus subtilis ATCC 6633 and Gram-negative bacteria: Escherichia coli ATCC 25922, Pseudomonas aeruginosa ATCC 27853, and Klebsiella pneumoniae ATCC 13883. For the determination of antifungal activity, various reference strains of Candida spp. were used: C. albicans ATCC 10231, C. glabrata ATCC 15126, C. glabrata ATCC 90030, C. krusei ATCC 14243, C. auris CDC B11903, C. lusitaniae ATCC 3449, and C. tropicalis ATCC 1369.
+ Open protocol
+ Expand
6

Microbial Detection Performance Evaluation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The following microorganism strains were used as indicated in the pharmacopoeial compendia for evaluating the growth-promoting ability of the culture media: Staphylococcus aureus (ATCC 6538), Bacillus subtilis (ATCC 6633), Pseudomonas aeruginosa (ATCC 9027), Clostridium sporogenes (ATCC 19404), Candida albicans (ATCC 10231), and Aspergillus brasiliensis (ATCC 16404). All microorganisms were obtained in the form of a BioBall® SingleShot (BioMerieux, France) containing approximately 30 colony-forming units (CFUs)/unit.
The performance for microbial detection of the BacT/Alert® SA, BacT/Alert® FA, BacT/Alert® iAST, BacT/Alert® iLym, and the conventional medium SCDM was evaluated using strains of S. aureus (ATCC 6538), P. aeruginosa (ATCC 9027), B. subtilis (ATCC 6633), A. brasiliensis (ATCC 16404), and C. albicans (ATCC 10231).
The performance for microbial detection of the BacT/Alert® SA, BacT/Alert® FA, BacT/Alert® iAST, BacT/Alert® iLym, and the conventional medium FTM was evaluated using strains of S. aureus (ATCC 6538), P. aeruginosa (ATCC 9027), and B. subtilis (ATCC 6633).
The performance for microbial detection of the BacT/Alert® SN, BacT/Alert® FN, BacT/Alert® iNST, and the conventional medium FTM was evaluated using strains of S. aureus (ATCC 6538), P. aeruginosa (ATCC 9027), B. subtilis (ATCC 6633), A. brasiliensis (ATCC 16404), and C. sporogenes (ATCC 19404).
+ Open protocol
+ Expand
7

Microbial Susceptibility to Medicaments

Check if the same lab product or an alternative is used in the 5 most similar protocols
This was an experimental in vitro study using a 2-factorial design: micro-organisms (E. faecalis [American Type Culture Collection {ATCC}-29212], S. aureus [ATCC-25923], Candida albicans [C. albicans, ATCC-90028]; ATCC, Belgaum, KA, India) and medicaments.
+ Open protocol
+ Expand
8

Antimicrobial Activity of Iris tuberosa Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the reagents were purchased from Sigma Aldrich (Madrid, Spain). Plants of Irirs tuberosa were collected in the Botanical Garden of Castilla-La Mancha (Albacete, Spain). Microoganisms were purchased from the American Type Culture Collection (Manassas, VA, USA) E. coli (ATCC25922), P. aureginosa (ATCC27853), S. aureus (ATCC 6538), C. albicans (ATCC 10231), and A. brasiliensis (ATCC16404).
+ Open protocol
+ Expand
9

Antimicrobial Evaluation of Common Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols

S. epidermidis (ATCC 12228), E. coli (ATCC 25922), S. aureus (ATCC 6538), C. albicans (ATCC 10231), A. flavus (ATCC MYA‐3631) and A. fumigatus (ATCC 96 918) were obtained from Guangdong Microbial Culture Collection Center. Bacteria were cultured under recommended conditions before experiments.
+ Open protocol
+ Expand
10

Antimicrobial Evaluation of Essential Oils

Check if the same lab product or an alternative is used in the 5 most similar protocols
Antimicrobial activity of the essential oils was individually assessed against a set of seven bacterial strains, Gram-positive bacteria S. aureus (ATCC 29737), S. epidermidis (ATCC 12228) and Bacillus subtilis (ATCC 6633), Gram-negative bacterial Pseudomonas aeruginosa (ATCC 27853), E. coli (ATCC 10536), Klebsiella pneumonia (ATCC 10031), Shigella dysenteriae (PTCC 1188), Salmonella paratyphi-A (ATCC 5702) and Proteus vulgaris (PTCC 1182), as well as tree fungi including two mold, Aspergillus brasiliensis (ATCC 1015) and A. niger (ATCC 16404) and one yeast, C. albicans (ATCC 10231), provided from Iranian Research Organization for Science and Technology (IROST).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!